Can a new pill slow Alzheimer's? major trial launches
NCT ID NCT07191028
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether MLC901 (NeuroAiD™II) can improve thinking and memory in people with mild to moderate Alzheimer's disease. About 350 adults aged 50 and older will receive either the study drug or a placebo for several months. Researchers will measure changes in cognitive tests and blood markers to see if the treatment is safe and effective.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE DEMENTIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National University Hospital Singapore
Singapore, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.